CombiMatrix Reports Preliminary Annual Growth in Prenatal Testing Volumes of 172% and 171% for Fourth Quarter and Year, Respectively

[at noodls] – Company Refocused Commercial Resources on Prenatal and Pediatric Markets Mid-2012 IRVINE, Calif., Jan. 7, 2013 (GLOBE NEWSWIRE) — CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company … more

View todays social media effects on CBMX

View the latest stocks trending across Twitter. Click to view dashboard

See who CombiMatrix is hiring next, click here to view